Search results
Updated Guideline Reflects New Drugs for Type 2 Diabetes
Medscape· 5 days agoThe American College of Physicians updated its existing guidelines to incorporate evidence on the...
What Endocrinologists Want You to Know About Rybelsus and Ozempic
Prevention via AOL· 1 day agoOn the other hand, for patients taking Ozempic 0.5 mg weekly, they can transition to Rybelsus 7 mg...
Do Virtual Behavior Interventions Lower T1D Distress?
Medscape· 5 days agoEducational and emotion-focused approaches conducted online in groups reduced diabetes distress and...
More and More Are Living With Type 1 Diabetes Into Old Age
Medscape· 4 days agoGlobal prevalence among adults aged 65 and older nearly doubled from 1990 to 2019.
New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for...
The Arab Tribune· 19 hours agoMedtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes Association's (ADA) 84th Scientific ...
...Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes...
Morningstar· 5 hours agoGL0034 administered once-weekly confirmed clinically meaningful weight loss and improved gluco-metabolic parameters over a 4-week treatment period in individuals with obesity, even in the lowest ...
The Most Controversial Form Of Scientific Discovery May Also Be The Most Effective
Inverse· 4 days agoFrom swallowing tapeworm eggs to having areas of his brain switched off, Mosley joined other medical pioneers who weren’t afraid to make use of their own bodies in the quest to learn more about ...
The 7 Best Anti-Inflammatory Options at Your Favorite Fast Food Spots, Recommended by Dietitians
Eating Well via Yahoo News· 3 days agoChick-fil-A: Market Salad Market Salad w/ Grilled...Filet (Cold and no dressing included) Nutrition...
Galmed Pharmaceuticals (NASDAQ:GLMD) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report published on Wednesday. The firm issued a sell rating on the biopharmaceutical company ...
Structure Therapeutics (NASDAQ:GPCR) Trading Down 9.3%
ETF DAILY NEWS· 6 days agoShares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) were down 9.3% during mid-day trading on Friday . The stock traded as low as $46.60 and last traded at $46.85. Approximately ...